RHT 0.00% 3.8¢ resonance health limited

Ann: Appendix 4C - quarterly, page-57

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 61 Posts.
    lightbulb Created with Sketch. 14
    I thought i would complile the 4C's from the last few years to see how things are tracking for RHT.
    Financials are looking pretty solid, really looking forward to the next 4C, due in the next few weeks.
    Apologies for the file being so big, first time posting like this.


    Appendix 4CRHTRHTRHTRHTRHTRHTRHTRHTRHTRHTRHTRHTRHTRHTRHT
    Quarterly report for entities subject to Listing Rule 4.7B
    Financial Year ended :-2016 / 20172017 / 20182018 / 2019
    Quarter ended :-30/09/201631/12/201631/03/201730/06/20172016/201730/09/201731/12/201731/03/201830/06/20182017/201830/09/201831/12/201831/03/201930/06/20192018/2019
    Consolidated statement of cash flows1st quarter $A’0002nd quarter $A’0003rd quarter $A’0004th quarter $A’000year to date $A’0001st quarter $A’0002nd quarter $A’0003rd quarter $A’0004th quarter $A’000year to date $A’0001st quarter $A’0002nd quarter $A’0003rd quarter $A’0004th quarter $A’000year to date $A’000% Change
    4C reporting date 28/10/201631/01/201728/04/201731/07/201731/10/201731/01/201823/04/201823/07/201829/10/201821/01/201916/04/2019
    Share Price at end of 4C report date$0.020$0.022$0.023$0.023$0.027$0.099$0.135
    1Cash flows from operating activities
    1.1Receipts from customers - actual324 775 661 531 2291 608 563 634 847 2652 680 907 961 840 3388 28%
    Receipts from customers - estimated540 790 814 589 681 712 654 2636 635 730 810 840 3015
    1.2Payments for
    (a) research and development - actual-59 -277 -136 -284 -756 -199 -58 -187 -139 -583 -110 -169 -147 -168 -594 2%
    (a) research and development - estimated-181 -220 -263 -228 -105 -110 -148 -591 -59 -100 -153 -168 -480
    (b) product manufacturing and operating costs0 0 0
    (c) advertising and marketing - actual-150 -168 -162 -154 -634 -164 -200 -125 -141 -630 -55 -86 -59 -53 -253 -60%
    (c) advertising and marketing - estimated-185 -120 -151 -130 -114 -137 -68 -449 -41 -61 -84 -53 -239
    (d) leased assets0 0 0
    (e) staff costs - actual-406 -395 -340 -391 -1532 -393 -469 -360 -387 -1609 -338 -363 -350 -357 -1408 -12%
    (e) staff costs - estimated-409 -350 -425 -378 -470 -350 -355 -1553 -348 -339 -351 -357 -1395
    (f) administration and corporate costs - actual-194 -15 -149 -101 -459 -150 -70 -89 -136 -445 -133 -88 -92 -90 -403 -9%
    (f) administration and corporate costs - estimated-223 -210 -170 -206 -191 -70 -60 -527 -144 -136 -89 -90 -459
    1.3Dividends received (see note 3)0 0 0
    1.4Interest received 13 5 10 28 4 3 3 5 15 6 5 6 17
    1.5Interest and other costs of finance paid0 0 0
    1.6Income taxes paid0 0 0
    1.7Government grants and tax incentives20 20 452 452 328 328
    1.8Other (provide details if material)315 315 0 0
    1.9Net cash from / (used in) operating activities-485 -67 -121 -54 -727 -294 -231 328 49 -148 50 534 319 172 1075 -826%

    2Cash flows from investing activities
    2.1Payments to acquire:
    (a) property, plant and equipment-20 0 0 -13 -33 -13 -6 0 -1 -20 -1 0 -2 -3
    (b) businesses (see item 10)0 0 0
    (c) investments 0 0 0
    (d) intellectual property0 0 0
    (e) other non-current assets0 0 0
    2.2Proceeds from disposal of:0 0 0
    (a) property, plant and equipment0 0 0
    (b) businesses (see item 10)0 0 0
    (c) investments 0 0 0
    (d) intellectual property0 0 0
    (e) other non-current assets0 0 0
    2.3Cash flows from loans to other entities0 0 0
    2.4Dividends received (see note 3)0 0 0
    2.5Other (provide details if material)-27 -27 0 0
    2.6Net cash from / (used in) investing activities-20 0 0 -40 -60 -13 -6 0 -1 -20 -1 0 -2 0 -3

    3Cash flows from financing activities
    3.1Proceeds from issues of shares
    3.2Proceeds from issue of convertible notes
    3.3Proceeds from exercise of share options
    3.4Transaction costs related to issues of shares, convertible notes or options
    3.5Proceeds from borrowings
    3.6Repayment of borrowings
    3.7Transaction costs related to loans and borrowings
    3.8Dividends paid
    3.9Other (provide details if material)
    3.1Net cash from / (used in) financing activities0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

    4Net increase / (decrease) in cash and cash equivalents for the period
    4.1Cash and cash equivalents at beginning of quarter/year to date2512 2042 1920 1863 1685 1363 1116 1477 1549 1609 2144 2468
    4.2Net cash from / (used in) operating activities (item 1.9 above)-485 -67 -121 -54 -727 -294 -231 328 49 -148 50 534 319 172 1075
    4.3Net cash from / (used in) investing activities (item 2.6 above)-20 0 0 -40 -60 -13 -6 0 -1 -20 -1 0 -2 0 -3
    4.4Net cash from / (used in) financing activities (item 3.10 above)0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    4.5Effect of movement in exchange rates on cash held35 -55 64 -84 -40 -15 -10 33 24 32 11 1 7 19
    4.6Cash and cash equivalents at end of quarter2042 1920 1863 1685 1363 1116 1477 1549 1549 1609 2144 2468 2640


    5Reconciliation of cash and cash equivalents
    at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts
    5.1Bank balances 2042 1920 1863 1685 1685 1363 1116 1477 1549 1549 1609 2144 2468 0
    5.2Call deposits
    5.3Bank overdrafts
    5.4Other (provide details)
    5.5Cash and cash equivalents at end of quarter (should equal item 4.6 above)2042 1920 1863 1685 1685 1363 1116 1477 1549 1549 1609 2144 2468 2640 2640

    6Payments to directors of the entity and their associates

    6.1Aggregate amount of payments to these parties included in item 1.235 39 45 45 164 35 35 35 35 140 60 55 70 185
    6.2Aggregate amount of cash flow from loans to these parties included in item 2.3
    6.3Explanation necessary to understand the transactions included in items 6.1 and 6.2Directors FeeDirectors FeeDirectors Fee Directors Fee Directors FeeDirectors Fee Directors Fee Directors Fee Directors Fee / Consultancy FeeDirectors Fee / Consultancy FeeDirectors Fee / Consultancy Fee


    7Payments to related entities of the entity and their associatesCurrent quarterCurrent quarter Current quarter Current quarter Current quarter Current quarterCurrent quarter Current quarter Current quarter Current quarter Current quarterCurrent quarter Current quarter Current quarter Current quarter
    $A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000$A'000
    7.1Aggregate amount of payments to these parties included in item 1.2
    7.2Aggregate amount of cash flow from loans to these parties included in item 2.3
    7.3Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2


    8Financing facilities availableTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter endTotal facility amount at quarter end
    Add notes as necessary for an understanding of the position
    8.1Loan facilities
    8.2Credit standby arrangements
    8.3Other (please specify)
    8.4Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.


    9Estimated cash outflows for next quarter
    9.1Research and development-181 -220 -263 -228 -892 -105 -110 -148 -59 -422 -100 -153 -168 -421
    9.2Product manufacturing and operating costs0 0 0
    9.3Advertising and marketing-185 -120 -151 -130 -586 -114 -137 -68 -41 -360 -61 -84 -53 -198
    9.4Leased assets 0 0 0
    9.5Staff costs -409 -350 -425 -378 -1562 -470 -350 -355 -348 -1523 -339 -351 -357 -1047
    9.6Administration and corporate costs-223 -210 -170 -206 -809 -191 -70 -60 -144 -465 -136 -89 -90 -315
    9.7Other (provide details if material)0 0 0
    9.8estimated cash outflows-998 -900 -1009 -942 -3849 -880 -667 -631 -592 -2770 -636 -677 -668 0 -1981
    9.9estimated receivables 540 790 814 589 2733 681 712 654 635 2682 730 810 840 2380
    9.1Total estimated cash outflows-458 -110 -195 -353 -1116 -199 45 23 43 -88 94 133 172 0 399

    10Acquisitions and disposals of business entitiesAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitionsAcquisitions
    (items 2.1(b) and 2.2(b) above)
    10.1Name of entity
    10.2Place of incorporation or registration
    10.3Consideration for acquisition or disposal
    10.4Total net assets
    10.5Nature of business
    https://hotcopper.com.au/data/attachments/1635/1635958-37946ababbe90b151bd81b7778c873e7.jpg
 
watchlist Created with Sketch. Add RHT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.000(0.00%)
Mkt cap ! $16.98M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $1.007K 26.51K

Buyers (Bids)

No. Vol. Price($)
4 427245 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 5000 1
View Market Depth
Last trade - 13.19pm 13/11/2024 (20 minute delay) ?
RHT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.